Wird geladen...
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
BACKGROUND: High-dose short-term methylprednisolone is the recommended treatment in the management of multiple sclerosis relapses, although it has been suggested that lower doses may be equally effective. Also, glucocorticoids are associated with multiple and often dose-dependent adverse effects. Th...
Gespeichert in:
| Veröffentlicht in: | BMC Neurol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609048/ https://ncbi.nlm.nih.gov/pubmed/26475456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0450-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|